Gladstone scientists reprogram skin cells into insulin-producing pancreas cells
A cure for type 1 diabetes has long eluded even the top experts. Not because they do not know what must be done—but because the tools did not exist to do it. But now scientists in the laboratory of Gladstone Institutes’ Investigator Sheng Ding, MD, PhD, harnessing the power of regenerative medicine, have developed a technique in animal models that could replenish the very cells destroyed by the disease. The team’s findings, published online today in the journal Cell Stem Cell, are an important step towards freeing patients from the life-long injections that characterize this devastating disease.
Type 1 diabetes, which usually manifests during childhood, is caused by the destruction of beta-cells (?-cells). ?-cells are a type of cell that normally resides in the pancreas and produces a hormone called insulin. Without insulin, the body’s organs have difficulty absorbing sugars, such as glucose, from the blood. Once a death sentence, the disease can now be managed with regular glucose monitoring and insulin injections. A more permanent solution, however, would be to replace the missing ?-cells. But these cells are hard to come by, so researchers have looked towards stem cell technology as a way to make them.
“The power of regenerative medicine is that it can potentially provide an unlimited source of functional, insulin-producing ?-cells that can then be transplanted into the patient,” said Dr. Ding. “But previous attempts to produce large quantities of healthy ?-cells—and to develop a workable delivery system—have not been entirely successful. So we took a somewhat different approach.”
One of the major challenges to generating large quantities of ?-cells is that these cells have limited regenerative ability; once they mature it’s difficult to make more. So the team decided to go one step backwards in the life cycle of the cell.
The team first collected skin cells, called fibroblasts, from laboratory mice. Then, by treating the fibroblasts with a unique ‘cocktail’ of molecules and reprogramming factors, they transformed the cells into endoderm-like cells. Endoderm cells are a type of cell found in the early embryo, and which eventually mature into the body’s major organs—including the pancreas, the home of ?-cells.
“Using another chemical cocktail, we then transformed these endoderm-like cells into cells that mimicked early pancreas-like cells, which we called PPLC’s,” said Gladstone Postdoctoral Scholar Ke Li, PhD, the paper’s lead author. “Our initial goal was to see whether we could coax these PPLC’s to mature into cells that, like ?-cells, respond to the correct chemical signals and—most importantly—secrete insulin. And our initial experiments, performed in a petri dish, revealed that they did.”
The research team then wanted to see whether the same would occur in live animal models. So they transplanted PPLC’s into mice modified to have hyperglycemia (high glucose levels), a key indicator of diabetes.
“Importantly, just one week post-transplant, the animals’ glucose levels started to decrease, and gradually approached normal levels,” continued Dr. Li. “And when we removed the transplanted cells, we saw an immediate glucose spike, revealing a direct link between the transplantation of the PPLC’s and reduced hyperglycemia.”
But it was when the team tested the mice eight weeks post-transplant that they saw more dramatic changes: the PPLC’s had given rise to functional, insulin-secreting ?-cells.
“These results not only highlight the power of small molecules in cellular reprogramming, and are proof-of-principle that could one day be used as a personalized therapeutic approach in patients,” explained Dr. Ding.
The Latest on: Type 1 Diabetes
[google_news title=”” keyword=”Type 1 Diabetes” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Type 1 Diabetes
- New Study Shows Low-Fat Vegan Diet Offers Hope for Type 1 Diabetes Patientson April 26, 2024 at 5:47 am
A study published in Clinical Diabetes has found that a low-fat vegan diet may offer new hope for adults with type 1 diabetes.
- Spencer Torkelson drops clothing collection, supports Juvenile Diabetes Research Foundationon April 26, 2024 at 3:11 am
KiwiClo, a Detroit-based clothing brand, is dropping a limited collection in collaboration with Detroit Tigers first baseman Spencer Torkelson.
- Breakthrough: Rare Gene Mutation Offers Clues to Preventing Type 1 Diabeteson April 25, 2024 at 8:39 pm
A unique genetic mutation in two siblings – that has never been seen in anyone else – has been discovered by UK researchers at the University of Exeter, pointing the way towards new treatment options ...
- Advanced insulin pumps enhance blood sugar management in type 1 diabeteson April 24, 2024 at 9:48 pm
Blood sugar levels improve when adults with type 1 diabetes use modern insulin pumps. These are the findings of a study conducted at the University of Gothenburg.
- Vertex jumps to TreeFrog to enhance production of Type 1 diabetes cell therapy candidateson April 24, 2024 at 4:25 am
Following success in cystic fibrosis and sickle cell disease, Vertex’s next big leap is Type 1 diabetes (T1D). | Following success in cystic fibrosis and sickle cell disease, Vertex’s next big leap is ...
- University of Birmingham: New International Medical Code Launched for Presymptomatic Type 1 Diabeteson April 23, 2024 at 4:37 am
Researchers at the University of Birmingham have partnered with NHS England to produce a diagnostic code tailored for individuals in the early phases of type 1 diabetes, enhancing patient prospects fo ...
- Type 1 on a GLP-1 Drug? Watch for Hypoglycemia and DKAon April 22, 2024 at 7:05 pm
Explore GLP-1 agonists for weight loss in type 1 diabetes with caution. Understand potential risks like hypoglycemia and DKA, while balancing benefits for heart and kidney health.
- Heritability of Type 1 Diabetes Higher for Pediatric- vs Adult-Onset Diseaseon April 22, 2024 at 5:35 am
Researchers conducted a register-based cohort study to compare the heritability of type 1 diabetes among individuals with pediatric- and adult-onset type 1 diabetes.
- Siblings with unique gene mutation offer insights into type 1 diabetes treatmenton April 20, 2024 at 10:51 pm
Two siblings who have the only known mutations in a key gene anywhere in the world have helped scientists gain new insights that could help progress the search for new treatments in type 1 diabetes.
- Preventing type 1 diabetes: UMass Chan researcher developing skin treatment, with potential broader applications to prevent diabeteson April 15, 2024 at 4:44 am
Dr. John Harris, professor and chair of the Department of Dermatology at UMass Chan Medical School in Worcester and founding director of the school’s Vitiligo Clinic and Research Center, Harris has ...
via Bing News